GSK
895 hedge funds and large institutions have $12.7B invested in GSK in 2024 Q3 according to their latest regulatory filings, with 89 funds opening new positions, 304 increasing their positions, 321 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 10 → 10 (0)
0.05% less ownership
Funds ownership: 7.53% → 7.48% (-0.05%)
5% less repeat investments, than reductions
Existing positions increased: 304 | Existing positions reduced: 321
Holders
895
Holding in Top 10
10
Calls
$200M
Puts
$104M
Top Buyers
| 1 | +$131M | |
| 2 | +$96.3M | |
| 3 | +$90.9M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$70.6M |
| 5 |
Millennium Management
New York
|
+$56.6M |
Top Sellers
| 1 | -$230M | |
| 2 | -$110M | |
| 3 | -$88.1M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
-$53.6M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$40.9M |